Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 02, 2018 09:00 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that...
The American Health Council Physician Board Appoints Laura Rainer, MD
November 24, 2017 08:00 ET
|
American Health Council
NEW YORK, Nov. 24, 2017 (GLOBE NEWSWIRE) -- Dr. Laura Rainer, Physician at Gulf Coast Medical Group, has been selected to join the Physician Board at the American Health Council. She will be sharing...
Crinetics Pharmaceuticals Initiates Phase 1 Study of Lead Candidate CRN00808 for Acromegaly
October 26, 2017 10:30 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced the...
Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease
September 06, 2017 09:00 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, announced today that...
Esoteric Testing Market worth over $35 billion by 2024: Global Market Insights, Inc.
July 24, 2017 05:30 ET
|
Global Market Insights, Inc
Ocean View, Delaware, July 24, 2017 (GLOBE NEWSWIRE) -- The Industry Growth report “Esoteric Testing Market By Test Type (Endocrinology, Infectious Disease & Immunology, Oncology,...
The American Health Council Names Paul Aoun, DO/PhD, to Board of Physicians
July 19, 2017 08:00 ET
|
American Health Council
NEW YORK, July 19, 2017 (GLOBE NEWSWIRE) -- With eight years in Endocrine and Diabetes Care and five years in his current role as Clinical Endocrinologist at Palm Beach Diabetes and Endocrine...
Crinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808
July 13, 2017 13:00 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, July 13, 2017 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, announced today that...
American Health Council Names Eric A. Widra, M.D. to Physician Board
July 10, 2017 11:23 ET
|
American Health Council
NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) -- Dr. Eric Widra, Physician and Medical Director at Shady Grove Fertility, has been selected to join the Physician Board at the American Health Council. He...
American Health Council Names Jaime Steinsapir, M.D., PhD, FACP, FACE to Physician Board
May 23, 2017 14:28 ET
|
American Health Council
NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- Dr. Jaime Steinsapir, Endocrinologist at Palm Beach Diabetes and Endocrine Specialists, PA has been selected to join the Physician Board at the American...
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical Endocrinology
May 05, 2017 09:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...